Effect of an 8 week pulmonary rehabilitation program in patients with interstitial lung diseases in India.

Devani, Poorvi; Pinto, Nicole; Jain, Priyanka; Pandey, Abha; Prabhudesai, Pralhad

doi:10.1183/13993003.congress-2018.pa828

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…6MWT is the most widely used investigation for assessing exercise tolerance in ILD patients. In the present study, distance walked by the patients during 6MWT was 332.4±67.0 m. This was similar to earlier studies by Devani et al (2019) and Gupta et al (2021) but other studies yielded higher values of 6MWD ( Fedi et al, 2021 ; Tremblay Labrecque et al, 2020 ). This difference could be due to variations in the body stature as well as due to difference in the extent of ILD in the mentioned studies.…”

Section: Discussionsupporting

confidence: 92%

Assessment of the feasibility of 1-min sit-to-stand test in evaluating functional exercise capacity in interstitial lung disease patients

Singh,

Aggarwal,

Dutta

et al. 2023

J Exerc Rehabil

View full text Add to dashboard Cite

Six-min walk test (6MWT) is widely used exercise test for the evaluation of interstitial lung disease (ILD). However, the long test duration and need for long and flat surface hinder its routine use. One-min sit-to-stand test (1-STST) is devoid of such limitations, but has been scarcely evaluated. The study was conducted to evaluate the performance of 1-STST by correlating it with 6MWT in ILD patients. Stable ILD patients were prospectively enrolled. After initial spirometry, all patients performed 6MWT and 1-STST following the standard recommendations. Exercise capacity and physiological parameters (heart rate, pulse oxygen saturation, blood pressure and dyspnea [modified Borg scale]) including peripheral oxygen saturation (SpO2) were correlated after the tests using Pearson correlation, Intraclass correlation coefficient (ICC) and kappa (κ) coefficient. The results showed that the mean age of the patients (n= 60) was 58.8± 11.5 years (male:female= 1:1). Repetitions after 1-STST showed significant correlation with 6MWT (r = 0.48; P< 0.001). Changes in the physiological variables were similar (P> 0.05) with good consistency (ICC= 0.68–0.95) between 6MWT and 1-STST. Both lowest SpO2 and difference in SpO2 also showed good agreement (ICC= 0.86; 95% confidence interval [CI], 0.77–0.92 and ICC= 0.68; 95% CI, 0.47–0.81 respectively) and significant correlation (r = 0.76 and r= 0.52, respectively). 1-STST and 6MWT were consistent in identifying patients having oxygen desaturation ≥ 4% (κ= 0.56; 96% CI, 0.30–0.82). The results demonstrated that the performance of 1-STST was consistent with 6MWT in terms of exercise capacity and change in physiological parameters. 1-STST can be a valid alternative to 6MWT in the assessment of ILD patients, especially in peripheral health centers.

show abstract

Section: Discussionsupporting

confidence: 92%

Assessment of the feasibility of 1-min sit-to-stand test in evaluating functional exercise capacity in interstitial lung disease patients

Singh,

Aggarwal,

Dutta

et al. 2023

J Exerc Rehabil

View full text Add to dashboard Cite

show abstract

“…Pulmonary rehabilitation is an important component of the support for the maintenance of function and quality of life of patients with IPF [ 112 , 113 , 114 , 115 ]. The number of randomized rehabilitation trials was low, and they included patients not only with IPF, but also with other ILDs, including those associated with systemic autoimmune diseases, NSIP, sarcoidosis, and HP [ 116 , 117 , 118 , 119 , 120 , 121 ]. Patients with ILDs other than IPF benefit from rehabilitation irrespective of the degree of lung function impairment [ 122 , 123 ].…”

Section: Resultsmentioning

confidence: 99%

Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis

Piotrowski

Martusewicz-Boros²,

Białas

et al. 2022

ARM

View full text Add to dashboard Cite

The recommendations were developed as answers to previously formulated questions concerning everyday diagnostic and therapeutic challenges. They were developed based on a review of the current literature using the GRADE methodology. The experts suggest that PF-ILD be diagnosed based on a combination of different criteria, such as the aggravation of symptoms, progression of radiological lesions, and worsening of lung function test parameters. The experts recommend a precise diagnosis of an underlying disease, with serological testing for an autoimmune disease always being included. The final diagnosis should be worked out by a multidisciplinary team (MDT). Patients with an interstitial lung disease other than IPF who do not meet the criteria for the progressive fibrosis phenotype should be monitored for progression, and those with systemic autoimmune diseases should be regularly monitored for signs of interstitial lung disease. In managing patients with interstitial lung disease associated with autoimmune diseases, an opinion of an MDT should be considered. Nintedanib rather than pirfenidon should be introduced in the event of the ineffectiveness of the therapy recommended for the treatment of the underlying disease, but in some instances, it is possible to start antifibrotic treatment without earlier immunomodulatory therapy. It is also admissible to use immunomodulatory and antifibrotic drugs simultaneously. No recommendations were made for or against termination of anti-fibrotic therapy in the case of noted progression during treatment of a PF-ILD other than IPF. The experts recommend that the same principles of non-pharmacological and palliative treatment and eligibility for lung transplantation should be applied to patients with an interstitial lung disease other than IPF with progressive fibrosis as in patients with IPF.

show abstract

Effect of an 8 week pulmonary rehabilitation program in patients with interstitial lung diseases in India.

Cited by 2 publications

References 0 publications

Assessment of the feasibility of 1-min sit-to-stand test in evaluating functional exercise capacity in interstitial lung disease patients

Assessment of the feasibility of 1-min sit-to-stand test in evaluating functional exercise capacity in interstitial lung disease patients

Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis

Contact Info

Product

Resources

About